Vertex Pharmaceuticals is expected to outshine projections when it reports Q1 2025 earnings, with strong sales from its ...

A local medical device startup has secured the FDA green light its pharmacist founder has been eyeing for more than a decade.

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...

TLX101-CDx is an investigational positron emission tomography agent that targets the membrane transport proteins, LAT1 and LAT2.

Between FDA progress, high-profile alliances, and a growing international presence, Avant Technologies continues to carve out a niche in the convergence of AI, diagnostics, and preventative care.

Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...

The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...

On VRTX's first-quarter earnings call, investors are likely to focus on the launch preparation for Alyftrek (vanza triple) ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

While there have been reports from drugmakers about possible interruptions with FDA matters due to staff layoffs, one company ...

The notion that we can simultaneously demand expedited approvals while gutting the agency is misguided.